Osteoclast progenitors from cats with and without tooth resorption respond differently to 1,25-dihydroxyvitamin D and interleukin-6

Res Vet Sci. 2012 Apr;92(2):311-6. doi: 10.1016/j.rvsc.2011.03.014. Epub 2011 Apr 16.

Abstract

Both vitamin D and inflammatory cytokines can stimulate osteoclast formation and activity. We studied the effect of 1,25-dihydroxycholecalciferol (1,25(OH)(2)D), and interleukin-6 (IL-6), on the formation and activity of feline osteoclasts, using peripheral blood mononuclear cells (PBMCs) from cats with and without tooth resorption (TR(+) and TR(-)) as a source of osteoclast precursors. The formation of osteoclast-like cells (defined as multinucleated, tartrate-resistant acid phosphatase-positive cells) was assessed at 7 and 14 days. In the presence of M-CSF and RANKL, with and without IL-6, more osteoclasts were formed from TR(-) PBMCs than from TR(+) PBMCs on plastic. More osteoclasts were formed from TR(+) PBMCs on bone slices in the presence of M-CSF/RANKL with 1,25(OH)(2)D. This opposite effect may be due to a higher expression of the vitamin D receptor (VDR) in TR(+) osteoclasts and precursors on bone. Formation of resorption pits was analyzed and confirmed with scanning electron microscopy. In conclusion, we propose that TR(+) PBMCs when cultured on bone are sensitive to 1,25(OH)(2)D, whereas the differentiation of TR(-) PMBCs on bone seem more sensitive to IL-6, suggesting that osteoclast precursors from cats with and without tooth resorption respond differently to osteoclast stimulating factors.

MeSH terms

  • Animals
  • Cats
  • Cells, Cultured
  • Female
  • Interleukin-6 / pharmacology*
  • Male
  • Osteoclasts / drug effects*
  • Osteoclasts / physiology
  • Stem Cells / drug effects
  • Time Factors
  • Tooth Resorption / physiopathology
  • Tooth Resorption / veterinary*
  • Vitamin D / analogs & derivatives*
  • Vitamin D / pharmacology

Substances

  • Interleukin-6
  • Vitamin D
  • 1,25-dihydroxyvitamin D